Range
28.22 - 31.26
Vol / Avg.
17.6K/36.7K
Div / Yield
-
52 Wk
19 - 38
Mkt Cap
712.9M
Payout Ratio
-
Open
28.16
P/E
-
EPS
-5.02
Shares
25M
Outstanding
25M
Total Float
-
Sector: Health Care.Industry: Pharmaceuticals
Calliditas Therapeutics AB is a biopharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.430-0.300 0.1300
REV10.000K0-10.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CALTCalliditas Therapeutics-0.07%712.9M

Calliditas Therapeutics Frequently Asked Questions

Q

How do I buy Calliditas Therapeutics (CALT) stock?

A

You can purchase shares of Calliditas Therapeutics (NASDAQ: CALT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Calliditas Therapeutics's (CALT) competitors?

Q

What is the target price for Calliditas Therapeutics (CALT) stock?

A

The latest price target for Calliditas Therapeutics (NASDAQ: CALT) was reported by Stifel on June 30, 2020. The analyst firm set a price target for 28.00 expecting CALT to fall to within 12 months (a possible -1.93% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Calliditas Therapeutics (CALT)?

A

The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $28.55 last updated Today at 4:14:09 PM.

Q

Does Calliditas Therapeutics (CALT) pay a dividend?

A

There are no upcoming dividends for Calliditas Therapeutics.

Q

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

A
Calliditas Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Calliditas Therapeutics (CALT) going to split?

A

There is no upcoming split for Calliditas Therapeutics.

Q

What sector and industry does Calliditas Therapeutics (CALT) operate in?

A

Calliditas Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.